C-Cog in Early Course Schizophrenia Study

PHASE4TerminatedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 23, 2024

Primary Completion Date

March 3, 2025

Study Completion Date

March 3, 2025

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole Lauroxil

1064 mg 2-month long-acting injectable administered as an intramuscular injection over a 12-month period.

BEHAVIORAL

Computerized cognitive and functional skills training

Self-administered cognitive and technology focused skills training, administered at home for 2 hours per week for the first 12 weeks of the 12-month study period.

Trial Locations (1)

33136

Jackson Memorial Hospital, Miami

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Alkermes, Inc.

INDUSTRY

lead

University of Miami

OTHER

NCT05662306 - C-Cog in Early Course Schizophrenia Study | Biotech Hunter | Biotech Hunter